SA
IBB icon

Sanctuary Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Sanctuary Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.8M Buy
51,503
+5,622
+12% +$966K 0.05% 410
2026
Q1 		$7.75M Buy
45,881
+6,112
+15% +$1.05M 0.04% 439
2025
Q4 		$6.71M Buy
39,769
+14,619
+58% +$2.37M 0.04% 473
2025
Q3 		$3.63M Sell
25,150
-1,182
-4% -$161K 0.02% 639
2025
Q2 		$3.33M Sell
26,332
-7,257
-22% -$891K 0.02% 639
2025
Q1 		$4.3M Sell
33,589
-2,249
-6% -$305K 0.03% 512
2024
Q4 		$4.98M Sell
35,838
-22,661
-39% -$3.19M 0.03% 504
2024
Q3 		$8.07M Sell
58,499
-5,681
-9% -$822K 0.05% 364
2024
Q2 		$8.12M Buy
+64,180
New +$8.57M 0.06% 330

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Sanctuary Advisors's IBB Position: Q2 2026 in Review

Sanctuary Advisors increased its iShares Biotechnology ETF (IBB) stake by 12% in Q2 2026, buying an estimated $966K and bringing the position to 51,503 shares worth $9.8M. The position accounts for 0.05% of the portfolio, ranked #410.

Sanctuary Advisors first reported a position in IBB in Q2 2024 and has held it in 9 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Sanctuary Advisors held 51,503 shares of iShares Biotechnology ETF worth $9.8M as of Q2 2026.
  • Sanctuary Advisors bought 5,622 iShares Biotechnology ETF shares in Q2 2026, an estimated $966K.
  • iShares Biotechnology ETF made up 0.05% of Sanctuary Advisors's portfolio in Q2 2026, its #410 holding.
  • Sanctuary Advisors first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 9 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.